Back to 
Brandes Investment Partners, LP
Brandes Investment Partners, LPGSGSK1
Showing 0 of 15 quarters
Position history for Brandes Investment Partners, LP's holdings in GLAXOSMITHKLINE PLC-SPON ADR
As of its Q2 2022 13F, Brandes Investment Partners held 709,630 shares of GSK1 (Glaxosmithkline), worth $30.9M. Brandes Investment Partners' 13F filings listed GSK1 from Q1 2019 to Q2 2022, 14 quarterly filings. GSK1 was 0.8% of Brandes Investment Partners' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.